Head and neck cancer
Clinical Trial to check the effectiveness of olanzapine drug in prevention weight loss in locally advanced head and neck cancer patients planned for chemoradiation
Who can joinAdults
Age18–65 years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
JIPMERPuducherry, PuducherryDirections ↗
Registry summary (technical)
Low-dose Olanzapine vs. Placebo in Preventing Weight Lossduring Radiation for Patients with Locally Advanced HNSCC:A Double Blinded RCT - Nil
Sponsor: JIPMER
CTRI/2024/11/076214 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 17 Nov 2025 · read by us 5 Nov 2026